Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Most people with hypothyroidism have skin problems like dry skin and hair loss.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Mice with autoimmune hair loss showed signs of heart problems.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Platelet-rich plasma therapy could be an effective treatment for melasma with minimal side effects.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.